slot gacor

situs togel terpercaya

toto togel 4d

toto slot

toto togel 4d

toto togel 4d

agen togel

situs togel

10 situs togel terpercaya

situs togel

https://ukinvestorshow.com

bo togel terpercaya

bo togel terpercaya

situs toto

situs togel terpercaya

Hydroxylchloroquine is Being Used to Treat COVID-19 in Nigeria – PTF

2 Min Read

The Presidential Task Force (PTF) on COVID-19 has revealed that a combination of Hydroxylchloroquine, Chloroquine, Azithmromycin, as well as several other anti-retroviral drugs are being used to treat Coronavirus infections in Nigeria.

This was revealed by Minister of Health, Osagie Enahire during the daily COVID-19 briefing on Friday.

“To see what medicines may work, we have tried chloroquine, hydroxychloroquine, azithromycin and some other combinations including antiretroviral drugs,” he said.

He also revealed that the much talked about herbal COVID-19 cure brought in from Madagascar has failed to work thus far.

See Also: Edo 2020: Why we’re backing Ize-Iyamu – APC House of Reps caucus

Enahire also said the herbal studies being carried out as possible cure for the virus has also not yielded any positive result.

The indigenous herbs that have been developed for the trial have not yielded any result.

“We are currently reviewing all the options that are possibilities for being remedies, recently we received samples from Madagascar which we are testing.” The minister revealed.

Asides from Nigeria, India and Senegal are also using a Hydroxylchloroquine combination to combat the disease.

The mainstream media as well as the WHO attacked US President Donald Trump when he also promoted the efficacy of the combination.

As a result the WHO temporarily cancelled clinical trials for the Malaria drug as a result of a study published on the Lancet at the time which said Hydroxylchloroquine was dangerous.

The study was however taken down after the data could not be independently verified. The Lancet also issued an apology for publishing the backwater study.

Share this Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *